Recent Advances in Chitosan-Based Nanoparticles for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 93
Special Issue Editor
Interests: nanomedicines; smart materials; biomaterials; functionalized chitosan nanoparticles; nanocomposites; controlled release
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chitosan is promising versatile biopolymer that had received particular attention in recent decades due to his physicochemical, biological, and antimicrobial characteristics. Due to their biocompatibility, biodegradability, nontoxicity, enhanced mucoadhesive capacity, and good bioavailability, chitosan nanoparticles can be successfully used in medicine as drug delivery systems. We invite you to submit a full research paper or review article for publication in our Special Issue, entitled “Recent Advances in Chitosan-Based Nanoparticles for Drug Delivery”. This Special Issue aims to focus on the synthesis and characterization of chitosan-based nanoparticles as drug delivery systems. Contributions should take into account the fundamental research of different types of chitosan based carriers, such as nanocapsules, nanospheres, solid lipid nanoparticles, micelles, nanogels, and chitosan-coated liposomes, and attention should also be paid to ligand-functionalized nanocarriers and hybrid nanoparticles containing inorganic particles (metal and metal oxide nanoparticles, quantum dots, etc.). Contributions should contain extensive experimental sections and a rigorous interpretation of the experimental results.
Dr. Delia Mihaela Raţă
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- drug delivery systems
- chitosan-coated liposomes
- solid lipid nanoparticles
- chitosan nanofibers
- conjugated polymers
- nanocomposites
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
